Universitätsklinikum Schleswig-Holstein (UKSH)

Hospital


Location: Lübeck / Kiel, Germany (DE) DE

ISNI: 0000000406462097

ROR: https://ror.org/01tvm6f46

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Research recommendations toward a better understanding of the causes of childhood leukemia (2011) Ziegelberger G, Baum C, Borkhardt A, Cobaleda C, Dasenbrock C, Dehos A, Grosche B, et al. Journal article, Original article Active immunization with amyloid-β 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system (2010) Vollmar P, Kullmann JS, Thilo B, Claussen MC, Rothhammer V, Jacobi H, Sellner J, et al. Journal article Therapeutic recommendations for mammary carcinoma Therapieempfehlungen bei mammakarzinom (2010) Mundhenke C Journal article Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer (2010) Bauerschlag DO, Habermann M, Weimer J, Meinhold-Heerlein I, Hilpert F, Weigel M, Bauer M, et al. Journal article Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial (2010) Witzel I, Loibl S, Von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, et al. Journal article Dexrazoxane (Savene) is the standard therapy for anthracycline extravasation Dexrazoxan (Savene) als Standard in der Therapie von Anthrazyklinparavasaten (2010) Mundhenke C Journal article Giant basal cell carcinoma of the breast mimicking Paget's disease: Complete remission after photodynamic therapy (2010) Mikhaimer NC, Kaehler KC, Schwarz T, Mundhenke C, Hauschild A Journal article Breast carcinoma - New aspects from practice and politics Mammakarzinom - Neue Aspekte aus Praxis und Politik (2010) Jonat W, Kreienberg R, Janni W, Mundhenke C Journal article Breast cancer therapies: Increasing costs in the age of targeted therapies. An unethical discussion? Mammakarzinomtherapie: Kostenentwicklung im zeitalter zielgerichteter therapien: Eine anstößige Diskussion? (2010) Mundhenke C, Schem C, Weigel M, Strauss A Journal article Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity (2010) Tchatchou S, Riedel A, Lyer S, Schmutzhard J, Strobel-Freidekind O, Gronert-Sum S, Mietag C, et al. Journal article